
BUSINESS
India or China? Macquarie finds the battle tough, but India takes an edge
Macquarie finds the choice between India and China challenging as China’s stimulus plans sparks hopes of revival despite persisting structural issues. However, India’s stronger fundamentals, with steady 6-7% GDP growth and robust corporate ROEs, continue to tilt the balance in its favor.

BUSINESS
Nifty, Sensex off to a jittery start ahead of major earnings; auto stocks take a hit
The market, having consolidated for the past few weeks, is expected to be driven by earnings performances due to a lack of other significant triggers.

BUSINESS
Uncertainty over China stimulus leaves metal stocks in a state of flux; clarity to reignite momentum
The uncertainty around China's stimulus has left metal stocks volatile, with investors awaiting clearer economic revival plans. While hopes for stronger measures still hold ground, analysts believe a sustained rally in metal stocks hinges on definitive government actions.

BUSINESS
Analyst Call Tracker: Divi's Labs wins back favour after Nifty 50 departure
While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from GLP-1 APIs, many brokerages also warned that these narratives are unlikely to materialise as quickly as investors expect.

BUSINESS
Q2 FY25 to see slowest earnings growth in 17 qtrs as high base, demand slump take toll
The BFSI sector is expected to drive Q2 earnings growth for Nifty yet again, albeit not with the same mojo. Global-facing sectors such as IT, pharma, and chemicals are likely to provide additional support, while growth in automobiles, industrials, and commodities may slow down.

BUSINESS
Metal stocks melt as China state planner's stimulus plans disappoint, iron ore prices tumble
China's National Development and Reform Commission (NDRC) disappointed investors by withholding major new stimulus measures, despite expressing confidence in meeting the country's economic target for the year.

BUSINESS
Nifty, Sensex extend downturn to sixth session, broader market bleeds
The Indian benchmarks bucked the positive global trend and dived in the red as investors dwindled with concerns over outflows to China, Q2 earnings growth moderation and geopolitical tensions in the Middle East.

BUSINESS
MOFSL forecasts Q2FY25 to deliver slowest Nifty earnings growth in 17 quarters
After four exciting years of double-digit growth, India Inc's earnings are expected to hit the brakes for a bit. According to MOFSL, this moderation is due to a mix of rising commodity pressures, dwindling tailwinds from improved BFSI asset quality, a high base, and a slight ease in demand.

BUSINESS
Short Call | Metals bask in the hopes of China's revival; M&M, Avenue Supermarts in focus
“In cyclicals, a period of silly prices is followed by a period of sobriety.” -- Peter Lynch

BUSINESS
Risk-off sentiment abounds in India amid geopolitical unrest, China's revival; here's where investors could find shelter
Amidst the prevailing uncertainties in the market, analysts suggest investors to take shelters in domestic focused sectors while warning that investments still need to be stock specific.

BUSINESS
UBS initiates 'sell' calls on slew of pharma majors; sees growth slowdown in India & US mkts
UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma and Cipla as its preferred bets in the pharmaceutical sector.

BUSINESS
Short Call: US dollar on a bumpy road, but not every currency will cash in the rough ride; BHEL, Skipper, Aadhar Housing Finance in focus
"The four most dangerous words in investing are, it’s different this time." —Sir John Marks Templeton

BUSINESS
Slowdown in urban consumption or change in preference? CLSA explains
Urban consumption trends, especially among young Indians, point to a shift in preferences towards experiences like events, dining out, travel, luxury and premium goods, fast fashion, cosmetics, and consumer electronics—leaving fries and pizzas behind.

BUSINESS
With markets at all-time highs, defensive plays gain favour
Over the past week, the rally in PSU stocks has cooled off significantly, with the BSE PSU index sliding nearly 4%. Meanwhile, defensive sectors have gained momentum, with the BSE FMCG and BSE Healthcare indices rising around 2%.

BUSINESS
Kalyan Jewellers surges 4% to record high; HSBC raises price target
Kalyan Jewellers shares are currently trading at a 10 percent valuation discount as compared to industry rival Titan, making it a lucrative buy for investors looking at the jewellery segment.

BUSINESS
Short Call: Rush to buy gold, but what are investors running from? CEAT, ONGC, Dixon Tech in focus
“Gold, much more so than any other commodity, is about sentiment and psychology.”—Peter Lynch

BUSINESS
Piramal Pharma stock surges to record high on heavy volumes, strong growth prospects
The passage of the draft US Biosecure Act has ushered a wave of optimism for Indian CDMO players in hopes of more work coming their way as US drugmakers look to shift manufacturing bases out of China.

BUSINESS
Upstream oil majors drop as much as 5% after Brent crude slips below $70
Brent crude prices dipped below $70 per barrel overnight for the first time since December 2021, as worries about sluggish demand, slowing economic growth, and the increasing shift towards electric vehicles weighed on the sentiment.

BUSINESS
The coming booster for Indian pharma stocks: US Biosecure Act
The US Biosecure Act aims to prohibit US drugmakers from engaging in business with five Chinese companies after eight years.

BUSINESS
Analyst Call Tracker Aug 2024: Apollo Hospitals falls out of favour in last one month despite upbeat growth narrative
Despite delivering better-than-expected results that gave investors plenty to rejoice, Apollo Hospitals stock still managed to snag the top spot on Moneycontrol's list of most downgraded stocks over the past month. Quite the plot twist!

BUSINESS
OMC and paint stocks cheer for fall in crude prices while ONGC and Oil India sulk into red
The fall in Brent crude prices is a double-edged sword in the stock market, benefiting some sectors while hurting others.

BUSINESS
Morgan Stanley upgrades PI Industries but Aarti Industries gets a downgrade
Morgan Stanley has raised price targets for some chemical stocks but also warned that the sector's earnings have not yet been fully de-risked.

BUSINESS
Why is SEBI facing flak over ICICI Bank-ICICI Securities merger case? | Explained
SEBI's handling of the merger between ICICI Bank and ICICI Securities has raised eyebrows, with many investors questioning the regulator's leniency in allowing the bank to bypass its own rules.

BUSINESS
Disparity in US stock performances gives hedge funds edge to cherry-pick and boost returns: Morgan Stanley
Morgan Stanley notes that hedge funds' have an advantage in generating both long and short alpha, thanks to their flexible approach compared to traditional benchmarks. This unconstrained strategy positions them well to achieve better returns in a market increasingly influenced by stock-specific performances.